Assay identifies rare tick-borne bacteria: Bobbi Pritt, M.D.

Bobbi Pritt, M.D., explains how Mayo Clinic Laboratories' new assay identifies less-common tick-borne bacteria in whole blood. The assay is recommended when tick-borne bacterial infection is suspected but standard testing is unrevealing.(00:33) Do you mind giving us a brief introduction of yourself and what you do at Mayo? (01:45) Can you tell us a little about the test and how it came to be? (03:00) Could you explain the types of patients this test would be best suited for and how a provider might determine if their patient would benefit from this? (03:32) Would you please explain why the algorithm is recommended and where in the algorithm this test fits? (04:36) What makes this test different from what's currently available to providers? (05:38) How can the information be used in patient care? And can you talk a little bit about how the diagnosis can be clarified by using this assay, why it's important, and how the results would impact a patient's care and treatment plan?